15.1 Antiglobulin Sera, Grouping Sera, and Reagent Red Cells

15.1 Antiglobulin Sera, Grouping Sera, and Reagent Red Cells

Quick Answer: Monoclonal reagents are single-clone, highly specific, and lot-consistent; polyclonal reagents recognize multiple epitopes. Modern anti-D is usually a monoclonal blend (IgM for immediate-spin D plus IgG for weak D). Anti-A and anti-B are typically monoclonal; anti-A,B catches some weak subgroups and confirms group O. AHG is anti-IgG, polyspecific (anti-IgG + anti-C3b/C3d), or anti-C3b/C3d. Check cells go into negative AHG tubes and must agglutinate or the test is invalid. Reagent red cells include screening cells, panel cells, A1 and B reverse cells, and cord cells. QC ABO/Rh/AHG each day of use. Store liquid reagents at 1–6 °C. Do not use them after expiration. High-protein Rh reagents require an Rh control; a reactive control invalidates the D type.

The June 9, 2026 BB outline parks reagents at IV.B. Routine grouping lives in Chapter 13. This section is the bottle on the rack: what is in it, what it can lie about, and how you prove it still works this morning.

Monoclonal versus polyclonal

A polyclonal reagent is a harvest of many B-cell clones, historically from an immunized human or animal. It sees multiple epitopes on the same antigen. That breadth helps when the antigen is heterogeneous (some D variants, some A subgroups), but the product varies by lot, can carry unwanted specificities, and is harder to standardize.

A monoclonal reagent is the product of a single hybridoma or recombinant clone. Specificity is narrow and reproducible. The failure mode is the opposite of polyclonal: a monoclonal anti-D aimed at one epitope can miss a partial D that lacks that epitope. Manufacturers therefore sell blends — two or more monoclonal antibodies in one dropper — so one clone’s blind spot is another clone’s epitope.

On the exam, the usable sentence is: monoclonal = more specific and more consistent; a blend is how the manufacturer covers partial-D and weak-A holes without going back to crude polyclonal serum.

ABO grouping sera

Anti-A and anti-B in current practice are almost always monoclonal IgM. They directly agglutinate at immediate spin. They are formulated as low-protein reagents (protein similar to normal serum, roughly 6%), so they do not spontaneously agglutinate IgG-coated cells the way a high-protein Rh reagent can.

Anti-A,B is not a lazy mixture you use instead of thinking. It is a reagent that:

• Confirms group O (O cells are nonreactive with anti-A, anti-B, and anti-A,B).
• Detects some weak A or B subgroups (especially Ax) that anti-A may miss.

Forward typing uses patient cells plus these sera. Reverse typing does not use grouping sera; it uses A1 and B reagent red cells plus patient plasma. Do not swap those sentences.

Rh reagents: blend anti-D, protein, and the control that saves you

Two historically different anti-D products still appear on BB items.

A blend anti-D typically pairs an IgM monoclonal that agglutinates most D-positive cells at immediate spin with an IgG monoclonal that finishes weak D at AHG. Some blends add a second IgM clone so a partial D that lacks one epitope still types D-positive as a donor. Patient versus donor interpretation of partial D is Chapter 7; the reagent point here is why the bottle says “blend.”

If the Rh control is positive, you do not have a D type. The cells are sticky — coating IgG, rouleaux, a potent cold, or the high-protein diluent itself. Wash, switch to a low-protein monoclonal, or reflex to genotyping. Never subtract a 1+ control from a 3+ anti-D and call the patient D-positive.

Low-protein anti-D does not get you out of a control when every grouping reagent agglutinates the cells or the DAT is already positive. Those are the stems where the manufacturer diluent, 6% albumin, or an inert control cell is still mandatory.

AHG: anti-IgG, polyspecific, anti-C3

Anti-human globulin bridges IgG or C3 already on red cells so you can see it. Chapter 10 gave the immunology. This chapter is the bottle and the QC.

A gel card labeled anti-IgG will not detect a complement-only coating. That is not a reagent failure; it is the wrong reagent for that question. A DAT workup that stops at “polyspecific positive” is incomplete — split it with anti-IgG and anti-C3.

AHG is neutralized by leftover serum globulin. That is why tube IAT/DAT washing exists, and why check cells exist.

Check cells

Check cells (Coombs control cells) are group O red cells coated with IgG. After you read an AHG test as negative, you add check cells and recentrifuge.

• Agglutination → AHG was present and active, and washing was adequate. The original negative result stands.
• No agglutination → the test is invalid. You may have forgotten AHG, used inactive AHG, or left unbound IgG in the tube so AHG was neutralized before it could find the test cells.

Check cells go into negative AHG tubes. They do not confirm a positive AHG result — those cells are already agglutinated. They also do not prove the original antibody was IgG versus complement; they only audit the AHG reagent and the wash.

Reagent red cells

Antibody-detection cells are group O so anti-A and anti-B in the patient do not agglutinate the panel.

Screening and panel cells expire on a short clock and hemolyze or lose antigen strength as they age. A visually hemolyzed vial is out of service even if the printed date has not arrived. Cord cells are not extra screening cells. They are an I/i reagent.

Daily QC, storage, expiration

Each day of use, control:

• ABO sera against known A, B, and O cells (the positive and negative reactions the SOP names).
• Anti-D against known D-positive and D-negative cells.
• AHG with IgG-coated cells (and a negative control as required). In many tube systems the check-cell lot plus a documented negative control satisfies the AHG check.

Visual inspection is QC: turbidity, precipitate, hemolysis, a black reagent-cell supernatant, a frozen bottle that was supposed to stay liquid.

Storage for liquid grouping sera, AHG, and reagent red cells is 1–6 °C. Do not freeze reagent red cells. Do not leave the rack on the bench for the whole shift and call that refrigerated. Expiration is a hard stop. An in-date hemolyzed screening cell is also a hard stop. Manufacturer inserts win when they are tighter than the generic 1–6 °C sentence.

Exam traps

• Reading a positive Rh control as “the patient is just strongly D-positive.”
• Using check cells on a positive AHG tube and thinking that validates the specificity.
• Storing AHG at room temperature “because it is used all day.”
• Treating cord cells as ordinary screening cells.
• Calling anti-A,B optional decoration rather than the reagent that finds some Ax cells and confirms O.
• Assuming every anti-D is high-protein. Most current bottles are low-protein monoclonal blends.